Autori: Bila Jelena S
| Naslov | Does Double Mean Trouble? Coexistence of Myeloproliferative and Lymphoproliferative Neoplasms (Article) |
| Autori | Lekovic Danijela R  Ivanovic Jelena Terzic Tatjana T Perunicic-Jovanovic Maja D Dencic-Fekete Marija Jovanovic Jelica V Arsenovic Isidora Vukovic Vojin M Bila Jelena S Bogdanovic Andrija D Antic Darko A
|
| Info | JOURNAL OF CLINICAL MEDICINE, (2024), vol. 13 br. 6, str. - |
| Ispravka | Web of Science Članak Elečas Rang časopisa |
     |
| Naslov | Efficacy and safety of melflufen plus daratumumab and dexamethasone in relapsed/refractory multiple myeloma: results from the randomized, open-label, phase III LIGHTHOUSE study (Article) |
| Autori | Pour Ludek ... Bila Jelena S ... (broj koautora 16)
|
| Info | HAEMATOLOGICA, (2024), vol. 109 br. 3, str. 895-905 |
| Projekat | [NCT04649060] |
| Ispravka | Web of Science Članak Elečas Rang časopisa |
|
|
| Naslov | Bortezomib-Cyclophosphamide-Dexamethasone (VCD) Vs Bortezomib-LenalidomideDexamethasone (VRD) in Newly Diagnosed Multiple Myeloma: A Matched Real-World Analysis from the Balkan Myeloma Study Group (BMSG) (Meeting Abstract) |
| Autori | Kastritis Efstathios ... Bila Jelena S ... Cvetkovic Zorica P Markovic Olivera B ... Sretenovic Aleksandra M ... (broj koautora 20)
|
| Info | BLOOD, (2023), vol. 142 br. , Suppl. 1, str. - |
| Ispravka | Web of Science Članak Elečas Rang časopisa |
|
|
| Naslov | Subcutaneous daratumumab plus pomalidomide and dexamethasone versus pomalidomide and dexamethasone in patients with relapsed or refractory multiple myeloma (APOLLO): extended follow up of an open-label, randomised, multicentre, phase 3trial (Article) |
| Autori | Dimopoulos Meletios Athanasios ... Bila Jelena S ... (broj koautora 21)
|
| Info | LANCET HAEMATOLOGY, (2023), vol. 10 br. 10, str. E813-E824 |
| Projekat | European Myeloma Network; Janssen Research Development |
| Ispravka | Web of Science Elečas Rang časopisa Citati: Web of Science |
|
|
| Naslov | Lighthouse: melflufen, daratumumab, and dexamethasone versus daratumumab in relapsed/refractory multiple myeloma refractory to an imid and a proteasome inhibitor or with ≥3 prior lines of therapy (Meeting Abstract) |
| Autori | Mateos Maria-Victoria Szarejko Monika Bila Jelena S Schjesvold Fredrik Spicka Ivan Maisnar Vladimir Jurczyszyn Artur Grudeva-Popova Zhanet Hajek Roman Usenko Hanna Thuresson Marcus Norin Stefan Jarefors Sara Richardson Paul Pour Ludek
|
| Info | CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, (2023), vol. 23 br. , Suppl. 2, str. S200-S201 |
| Ispravka | Web of Science Elečas Rang časopisa |
|
|
| Naslov | The second revision of international staging system (R2-ISS) in newly diagnosed multiple myeloma patients: RWE settings (Meeting Abstract) |
| Autori | Sretenovic Aleksandra M Mitrovic Marko Vukosavljevic Nikola Kecman Natalija Jovanovic Jelica V Bukumiric Zoran M Bila Jelena S
|
| Info | CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, (2023), vol. 23 br. , Suppl. 2, str. S93-S93 |
| Ispravka | Web of Science Elečas Rang časopisa |
|
|
| Naslov | MajesTEC-4: Phase 3 trial of Teclistamab plus Lenalidomide versus Lenalidomide in patients with newly diagnosed multiple myeloma (Meeting Abstract) |
| Autori | Cook Gordon ... Bila Jelena S ... (broj koautora 22)
|
| Info | BRITISH JOURNAL OF HAEMATOLOGY, (2023), vol. 201 br. , Suppl. 1, str. 57-57 |
| Ispravka | Web of Science Elečas Rang časopisa |
|
|
| Naslov | Prevention and management of adverse events during treatment with bispecific antibodies and CAR T cells in multiple myeloma: a consensus report of the European Myeloma Network (Review) |
| Autori | Ludwig Heinz ... Bila Jelena S ... (broj koautora 29)
|
| Info | LANCET ONCOLOGY, (2023), vol. 24 br. 6, str. E255-E269 |
| Projekat | Austrian Forum Against Cancer |
| Ispravka | Web of Science Elečas Rang časopisa |
|
|
| Naslov | MajesTEC-4 (EMN30): A Phase 3 Trial of Teclistamab plus Lenalidomide Versus Lenalidomide Alone As Maintenance Therapy Following Autologous Stem Cell Transplantation in Patients with Newly Diagnosed Multiple Myeloma (Meeting Abstract) |
| Autori | Zamagni Elena ... Bila Jelena S ... (broj koautora 22)
|
| Info | BLOOD, (2022), vol. 140 br. , Suppl. 1, str. 7289-7291 |
| Ispravka | Web of Science Članak Elečas Rang časopisa |
|
|
| Naslov | Subcutaneous Daratumumab Plus Pomalidomide and Dexamethasone (D-Pd) Versus Pomalidomide and Dexamethasone (Pd) Alone in Patients with Relapsed or Refractory Multiple Myeloma (RRMM): Overall Survival Results from the Phase 3 Apollo Study (Meeting Abstract) |
| Autori | Dimopoulos Meletios A Terpos Evangelos Boccadoro Mario Delimpasi Sosana Beksac Meral Katodritou Eirini Moreau Philippe Baldini Luca Symeonidis Argiris Bila Jelena S Oriol Albert Mateos Maria-Victoria Einsele Hermann Orfanidis Ioannis Kampfenkel Tobias Liu Weiping Kosh Michele NamPhuong Tran Carson Robin Sonneveld Pieter
|
| Info | BLOOD, (2022), vol. 140 br. , Suppl. 1, str. 7272-7274 |
| Ispravka | Web of Science Članak Elečas Rang časopisa |
|
|
